2021 FDA approvals
Publication type: Journal Article
Publication date: 2022-01-04
scimago Q1
wos Q1
SJR: 30.506
CiteScore: 181.8
Impact factor: 101.8
ISSN: 14741776, 14741784
PubMed ID:
34983958
Drug Discovery
General Medicine
Pharmacology
Abstract
The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease. The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Drug Discovery Today
4 publications, 3.81%
|
|
|
International Journal of Molecular Sciences
3 publications, 2.86%
|
|
|
European Journal of Medicinal Chemistry
3 publications, 2.86%
|
|
|
Journal of Medicinal Chemistry
3 publications, 2.86%
|
|
|
Cancers
2 publications, 1.9%
|
|
|
Molecular Pharmaceutics
2 publications, 1.9%
|
|
|
Nature Communications
2 publications, 1.9%
|
|
|
Scientific Reports
2 publications, 1.9%
|
|
|
Journal of the American Society of Nephrology : JASN
1 publication, 0.95%
|
|
|
Biomedicines
1 publication, 0.95%
|
|
|
Biomolecules
1 publication, 0.95%
|
|
|
Molecules
1 publication, 0.95%
|
|
|
Antibodies
1 publication, 0.95%
|
|
|
International Journal of Impotence Research
1 publication, 0.95%
|
|
|
Nature Reviews Chemistry
1 publication, 0.95%
|
|
|
Journal of Solution Chemistry
1 publication, 0.95%
|
|
|
Journal of General Internal Medicine
1 publication, 0.95%
|
|
|
InFo Hämatologie + Onkologie
1 publication, 0.95%
|
|
|
European Review of Aging and Physical Activity
1 publication, 0.95%
|
|
|
The Lancet Oncology
1 publication, 0.95%
|
|
|
Regulatory Toxicology and Pharmacology
1 publication, 0.95%
|
|
|
Analytical Science Advances
1 publication, 0.95%
|
|
|
Bioengineering & Translational Medicine
1 publication, 0.95%
|
|
|
Advanced Materials
1 publication, 0.95%
|
|
|
Analytical Chemistry
1 publication, 0.95%
|
|
|
Entrepreneurship and Innovation Policy and the Economy
1 publication, 0.95%
|
|
|
Medicinal Research Reviews
1 publication, 0.95%
|
|
|
Frontiers in Pharmacology
1 publication, 0.95%
|
|
|
Journal of Chemical Theory and Computation
1 publication, 0.95%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
|
|
|
Springer Nature
22 publications, 20.95%
|
|
|
Elsevier
17 publications, 16.19%
|
|
|
Wiley
14 publications, 13.33%
|
|
|
American Chemical Society (ACS)
13 publications, 12.38%
|
|
|
MDPI
11 publications, 10.48%
|
|
|
Oxford University Press
5 publications, 4.76%
|
|
|
Taylor & Francis
3 publications, 2.86%
|
|
|
Frontiers Media S.A.
2 publications, 1.9%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.9%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 1.9%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.9%
|
|
|
American Society of Nephrology
1 publication, 0.95%
|
|
|
University of Chicago Press
1 publication, 0.95%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.95%
|
|
|
Canadian Science Publishing
1 publication, 0.95%
|
|
|
Society of Hospital Medicine
1 publication, 0.95%
|
|
|
IntechOpen
1 publication, 0.95%
|
|
|
Medknow
1 publication, 0.95%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.95%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.95%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.95%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.95%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
105
Total citations:
105
Citations from 2024:
44
(41.91%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/d41573-022-00001-9
UR - https://doi.org/10.1038/d41573-022-00001-9
TI - 2021 FDA approvals
T2 - Nature Reviews Drug Discovery
AU - Mullard, Asher
PY - 2022
DA - 2022/01/04
PB - Springer Nature
SP - 83-88
IS - 2
VL - 21
PMID - 34983958
SN - 1474-1776
SN - 1474-1784
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Mullard,
author = {Asher Mullard},
title = {2021 FDA approvals},
journal = {Nature Reviews Drug Discovery},
year = {2022},
volume = {21},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038/d41573-022-00001-9},
number = {2},
pages = {83--88},
doi = {10.1038/d41573-022-00001-9}
}
Cite this
MLA
Copy
Mullard, Asher. “2021 FDA approvals.” Nature Reviews Drug Discovery, vol. 21, no. 2, Jan. 2022, pp. 83-88. https://doi.org/10.1038/d41573-022-00001-9.